Oncotarget Protein-Based Risk Model Predicts Esophageal Cancer Recurrence Researchers developed a multi-protein expression-based risk model to predict recurrence-free survival for ESCC patients.The... read more September 23, 2022
Oncotarget Does a Mechanism Linking Cellular Aging to Cellular Quiescence Exist? Researchers found that diverse geroprotectors differently affect a mechanism linking cellular aging to cellular quiescence... read more August 5, 2022
Oncotarget How Heartburn Can Turn Into Esophageal Cancer, and a Possible Biomarker In a recent Oncotarget paper, researchers investigated telomere shortening in patients with Barrett's esophagus as... read more July 15, 2022
Oncotarget New Tool Uses NF-κB Activity to Classify HPV+ Head and Neck Cancer Researchers developed a new tool aimed at better classifying HPV+ HNSCC patients with good or... read more May 26, 2022
Oncotarget Trending With Impact: Analysis of Mutational Burden in NSCLC Researchers conducted a multi-site cohort study of tumor mutational burden among hundreds of patients diagnosed... read more April 21, 2022
Oncotarget Trending With Impact: Genes Identified in Endocrine Therapy Resistance Researchers studied the dynamic behavior of gene expression during the development of endocrine therapy resistance... read more April 14, 2022
Oncotarget Novel Therapeutic Strategies Against Endometrial Cancer In a new study, researchers investigated the role of the (pro)renin receptor in endometrial... read more April 6, 2022
Oncotarget Trending With Impact: Adjunct Virotherapy Fights Multiple Myeloma Researchers investigated using oncolytic viruses to treat multiple myeloma—alone and in a combination approach.... read more March 17, 2022
Oncotarget Trending With Impact: Are NOTCH1 Variants Prognostic in Breast Cancer? Researchers determined the prognostic ability of three NOTCH1 gene variants by incorporating them into two... read more February 24, 2022
Oncotarget Trending With Impact: New Pre-Transplant AML Treatment Combinations Researchers aimed to improve acute myeloid leukemia (AML) patient outcomes after allo-HSCT with new pre-transplant... read more February 17, 2022